Expert consensus on standard clinical management of neonatal hypoglycemia in China (2021)

    Insights

    This consensus offers 21 recommendations for preventing and managing neonatal hypoglycemia in infants born at or after 35 weeks gestation. It aims to standardize care and reduce neurological damage from low blood sugar in newborns.

    Area of Science:

    • Neonatology
    • Pediatric Medicine
    • Clinical Practice Guidelines

    Background:

    • Neonatal hypoglycemia poses significant risks, including irreversible neurological damage.
    • Current clinical management in China lacks unified guidelines, relying on international protocols.
    • Standardized prevention and management are crucial for reducing incidence and brain injury.

    Purpose of the Study:

    • To develop unified clinical management guidelines for neonatal hypoglycemia in China.
    • To standardize the prevention, monitoring, and management of neonatal hypoglycemia.
    • To address clinical issues for neonates with gestational age ≥35 weeks.

    Main Methods:

    • Development of a consensus by the Group of Neonatology, Pediatric Society, Chinese Medical Association.
    • Formulation of 21 recommendations based on clinical issues.
    • Focus on neonates with a gestational age of ≥35 weeks.

    Main Results:

    • A comprehensive set of 21 recommendations for clinical practice.
    • Guidelines tailored for the Chinese context.
    • Focus on early detection and intervention strategies.

    Conclusions:

    • The consensus provides a standardized framework for managing neonatal hypoglycemia.
    • Implementation can improve clinical outcomes and reduce long-term complications.
    • A unified approach is essential for effective neonatal care in China.

    Related Concept Videos

    Hypoglycemia and Glucagon01:15

    Hypoglycemia and Glucagon

    Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
    365
    Diabetes: Management and Pharmacotherapy01:15

    Diabetes: Management and Pharmacotherapy

    The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
    Insulin remains the cornerstone of treatment for most patients with type 1 and many...
    428
    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    3.1K
    Acute Pancreatitis II: Clinical Manifestations and Management01:30

    Acute Pancreatitis II: Clinical Manifestations and Management

    Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
    190
    SBAR II: Application of SBAR01:14

    SBAR II: Application of SBAR

    SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
    SBAR Report from a Nurse to a Health Care Provider
    S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
    4.9K
    Pathophysiology of Diabetes01:20

    Pathophysiology of Diabetes

    Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
    Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
    1.5K